|
|
Article: Advanced Biotherapy Restated 2004, 2005 and 2006 Financial Statements.
- Article from:
- Business Wire
- Article date:
- January 12, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CHICAGO -- Advanced Biotherapy, Inc. (OTCBB:ADVB) announced today that it restated its 2004 and 2005 audited financial statements and its 2006 quarterly unaudited financial statements as follows:
[TABLE OMITTED]
Company President and Chief Executive Officer, Christopher W. Capps said today that "the restatements correct accounting items identified by the Securities and Exchange Commission and, with the oversight of the Company's Audit Committee, we have instituted procedures to avoid such errors in the future."
About Advanced Biotherapy
The Company, a pioneer in anticytokine therapy, has demonstrated the effectiveness of its pioneering ...